Department of Microbiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
PLoS One. 2011 Jan 24;6(1):e16122. doi: 10.1371/journal.pone.0016122.
Herpes virus entry mediator (HVEM) is one of two principal receptors mediating herpes simplex virus (HSV) entry into murine and human cells. It functions naturally as an immune signaling co-receptor, and may participate in enhancing or repressing immune responses depending on the natural ligand used. To investigate whether engagement of HVEM by HSV affects the in vivo response to HSV infection, we generated recombinants of HSV-2(333) that expressed wild-type gD (HSV-2/gD) or mutant gD able to bind to nectin-1 (the other principal entry receptor) but not HVEM. Replication kinetics and yields of the recombinant strains on Vero cells were indistinguishable from those of wild-type HSV-2(333). After intravaginal inoculation with mutant or wild-type virus, adult female C57BL/6 mice developed vaginal lesions and mortality in similar proportions, and mucosal viral titers were similar or lower for mutant strains at different times. Relative to HSV-2/gD, percentages of HSV-specific CD8(+) T-cells were similar or only slightly reduced after infection with the mutant strain HSV-2/gD-Δ7-15, in all tissues up to 9 days after infection. Levels of HSV-specific CD4(+) T-cells five days after infection also did not differ after infection with either strain. Levels of the cytokine IL-6 and of the chemokines CXCL9, CXCL10, and CCL4 were significantly lower in vaginal washes one day after infection with HSV-2/gD compared with HSV-2/gD-Δ7-15. We conclude that the interaction of HSV gD with HVEM may alter early innate events in the murine immune response to infection, without significantly affecting acute mortality, morbidity, or initial T-cell responses after lethal challenge.
单纯疱疹病毒进入介体(HVEM)是介导单纯疱疹病毒(HSV)进入鼠类和人类细胞的两个主要受体之一。它作为天然的免疫信号共受体发挥作用,并且根据使用的天然配体,可能参与增强或抑制免疫反应。为了研究 HSV 与 HVEM 的相互作用是否影响 HSV 感染的体内反应,我们生成了表达野生型 gD(HSV-2/gD)或突变 gD 的 HSV-2(333)重组体,突变 gD 能够与神经纤毛蛋白-1(另一个主要进入受体)结合,但不能与 HVEM 结合。重组株在 Vero 细胞上的复制动力学和产量与野生型 HSV-2(333)没有区别。在阴道接种突变或野生型病毒后,成年雌性 C57BL/6 小鼠以相似的比例出现阴道病变和死亡率,并且在不同时间,突变株的粘膜病毒滴度相似或较低。与 HSV-2/gD 相比,在感染突变株 HSV-2/gD-Δ7-15 后,所有组织中 HSV 特异性 CD8(+)T 细胞的百分比相似或仅略有减少,感染后 9 天内。感染后 5 天,两种菌株感染后,HSV 特异性 CD4(+)T 细胞的水平也没有差异。感染后一天,阴道冲洗液中细胞因子 IL-6 和趋化因子 CXCL9、CXCL10 和 CCL4 的水平也明显低于 HSV-2/gD。我们的结论是,HSV gD 与 HVEM 的相互作用可能改变了感染后鼠类免疫反应中的早期先天事件,而不会显著影响急性死亡率、发病率或致死性挑战后的初始 T 细胞反应。